Iron Deficiency Anemia (Ulcerative Colitis/Crohn's Disease)
Dr. Jason Hou is participating in a clinical trial on behalf of Shield Therapeutics that compares an investigational oral iron medication called ferric maltol versus an intravenous iron therapy (ferric carboxymaltose) in the treatment and maintenance of iron deficiency anemia (IDA) in subjects with inflammatory bowel disease (IBD).
You might qualify to participate if you:
• Are age 18 years or older
• Have a confirmed diagnosis of IBD (endoscopic and/or biopsy)
• Have iron deficiency anemia